NCT00132639View on ClinicalTrials.gov

Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC)

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Pulmonary Neoplasms
Interventions
DRUG

Preoperative docetaxel-cisplatin combination chemotherapy

Preoperative docetaxel-cisplatin combination chemotherapy

DRUG

Preoperative docetaxel monotherapy

Preoperative docetaxel monotherapy

Trial Locations (1)

104-0045

National Cancer Center, Chuo-ku,Tsukiji,5-1-1

All Listed Sponsors
collaborator

Ministry of Health, Labour and Welfare, Japan

OTHER_GOV

lead

Haruhiko Fukuda

OTHER

NCT00132639 - Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter